Derivation and External Validation of a Prediction Rule for Five‐Year Mortality in Patients With Early Diffuse Cutaneous Systemic Sclerosis
- 28 March 2016
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 68 (4) , 993-1003
Abstract
Objective: Although diffuse cutaneous systemic sclerosis (dcSSc) is associated with a reduction in life expectancy, there are no validated prognostic models for determining 5‐year mortality in patients with dcSSc. The objective of this study was to derive and validate a rule for predicting 5‐year mortality in patients with early dcSSc.Methods: We studied an inception cohort of 388 US Caucasian patients with early dcSSc (<2 years from the appearance of the first symptom). Predefined baseline variables were analyzed in a stepwise logistic regression model in order to identify factors independently associated with 5‐year all‐cause mortality. We rounded the beta weights to the nearest integer and summed the points assigned to each variable in order to stratify patients into low‐risk (<0 points), moderate‐risk (1–2 points), and high‐risk (≥3 points) groups. We then applied this rule to an external validation cohort of 144 Caucasian patients with early dcSSc from the Royal Free Hospital cohort and compared stratum‐specific 5‐year mortality.Results: Six independent predictors (rounded beta weight) comprised the model: age at first visit (points allotted: −1, 0, or 1), male sex (points allotted: 0 or 1), tendon friction rubs (points allotted: 0 or 1), gastrointestinal involvement (points allotted: 0 or 1), RNA polymerase III antibodies (points allotted: 0 or 1), and anemia (points allotted: 0 or 1). The 3‐level risk stratification model performed well, with no significant differences between the US derivation cohort and the UK validation cohort.Conclusion: We derived and externally validated, in US and UK cohorts, an easy‐to‐use 6‐variable prediction rule that assigns low‐risk, moderate‐risk, and high‐risk categories for 5‐year mortality in patients with early dcSSc. Only history, physical examination, and basic laboratory assessments are required.Keywords
Funding Information
- NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases) (K23-AR-057845)
This publication has 33 references indexed in Scilit:
- Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centresAnnals of the Rheumatic Diseases, 2011
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnnals of the Rheumatic Diseases, 2010
- Clinical and genetic factors predictive of mortality in early systemic sclerosisArthritis Care & Research, 2009
- Survival and causes of death in 366 Hungarian patients with systemic sclerosisAnnals of the Rheumatic Diseases, 2008
- Systemic Sclerosis Mortality in the United States: 1979–1998European Journal of Epidemiology, 2005
- Predicting Mortality in Systemic SclerosisMedicine, 2002
- Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical featuresAmerican Heart Journal, 1985
- Progressive Systemic Sclerosis in Auckland: A Ten Year Review with Emphasis on Prognostic FeaturesAustralian and New Zealand Journal of Medicine, 1981
- Survival with scleroderma—II: A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patientsJournal of Chronic Diseases, 1973
- Prognostic Significance of Raynaud's Phenomenon and Other Clinical Characteristics of Systemic SclerodermaCirculation, 1960